Healthcare Market Research Blog
Expert Insights in Healthcare Market Research
At MedPanel, our Healthcare Market Research Blog provides valuable insights into patient recruitment, physician research (How We Work), and emerging healthcare industry trends. Additionally, we share expert perspectives on rare disease studies (Rare Disease Research), specialty healthcare research, and evolving market challenges across pharmaceutical, biotech, and medical device sectors. Furthermore, our blog highlights proven strategies for improving study efficiency, enhancing participant engagement, and maintaining high-quality research outcomes, supported by our healthcare research methodologies (How We Work) and global market research expertise .
Real-World Evidence and HEOR in Rare Diseases
March 25, 2019
Real-world evidence (RWE) plays a critical role in health economics and outcomes research (HEOR), especially in rare diseases where clinical trials are often challenging. Because patient populations are small and symptoms can vary widely, trials may provide limited insights. Therefore, organizations can use RWE to improve decision-making, while also referring to FDA Real-World Evidence Guidance for additional industry guidance.
Informing HEOR Models with Primary Market Research in Rare Diseases
January 19, 2026
HEOR models are only as credible as the inputs behind them, especially in rare diseases where data is often limited. Because natural history is poorly characterized, endpoints are inconsistent, and patient populations are small, uncertainty increases in both clinical and economic parameters. Therefore, strong real-world data becomes essential for improving model accuracy and supporting better healthcare decisions. Additionally, organizations can refer to Rare Disease Research Insights for further understanding of real-world data challenges and healthcare decision-making.
Rare Disease Treatment Challenges and Physician Perspectives
April 29, 2019
Key Challenges in Rare Disease Management
100 rare disease specialists in the US and UK shared key challenges in managing patients. Because rare conditions involve delayed diagnosis, limited treatments, and complex care, healthcare professionals face major barriers.
Why This Matters
Therefore, understanding these challenges helps improve strategies and patient outcomes. Additionally, organizations can refer to Rare Disease Care Insights for deeper understanding.
MedPanel Insights: Pharma involvement in rare disease patient groups
March 25, 2019
MedPanel asked 100 rare disease treaters in the US and the UK if pharmaceutical companies should be involved in rare disease patient advocacy groups. Because patient advocacy plays a major role in awareness, education, and support, industry involvement can significantly influence patient care and access. Therefore, understanding healthcare professional perspectives helps shape stronger collaboration strategies. Additionally, organizations can refer to Rare Disease Advocacy Insights for further understanding of patient advocacy and industry partnerships.
MedPanel Insights: Rare disease treaters share their needs in managing patients
February 28, 2019
Doctors treating rare disease patients work across multiple care settings and often face challenges staying updated with treatment advances. Because rare diseases require specialized knowledge and ongoing education, support from pharmaceutical companies can play an important role in improving care. Therefore, understanding these needs helps strengthen physician support and patient outcomes. Additionally, organizations can refer to Rare Disease Treatment Insights for further understanding of care settings and treatment challenges.
Rare Disease Research Support and Industry Collaboration
February 21, 2019
MedPanel’s Rare Disease Initiative
MedPanel launched RareDiseaseMatters.com to provide consulting, research, and patient recruitment support for pharmaceutical and biotechnology companies focused on rare diseases. Because rare disease research often involves hard-to-reach patient populations and complex study requirements, specialized support is essential for better outcomes.
Improving Research Outcomes
Therefore, this new division helps organizations improve recruitment efficiency and research success. Additionally, companies can refer to Rare Disease Research Support for further insights into rare disease patient advocacy and research resources.
Let’s connect at Rare Disease Week, Feb 24th – 28th in DC
January 27, 2019
MedPanel has long been a leader in rare disease market research and launched RareDiseaseMatters.com to better support the growing needs of its clients. Because rare disease studies require specialized expertise and access to niche patient populations, dedicated research solutions are increasingly important. Therefore, this initiative strengthens support for customers across consulting, recruitment, and market research. Additionally, organizations can refer to Rare Disease Week Resources for further insights into rare disease advocacy and industry collaboration.